Aerpio Pharmaceuticals-Aadi Bioscience, Inc. (AADI) Reports Q2 Loss, Lags Revenue Estimates

Aadi Bioscience, Inc. (AADI) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of$ 0.71. This compares to loss of $0.67 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 23.94%. A quarter ago, it was expected that this company would post a loss of$ 0.66 per share when it actually produced a loss of $0.68, delivering a surprise of -3.03%.Over the last four quarters, the company has su ...